83 reports

Bladder Cancer:

  • Bladder Cancer
  • World
  • Smoking Prevalence
  • Cancer Incidence

Top Companies Participating in Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Therapeutics Clinical Trials

  • Bladder Cancer
  • Clinical Trial
  • G7
  • APAC

Abstract: - Global Bladder Cancer Therapeutics Market to Reach $308.2 Million by 2027 - Amid the COVID-19 crisis, the global market for Bladder Cancer Therapeutics estimated at US$242.6 Million in the year 2020, is projected to reach a revised size of US$308.2 Million by 2027, growing at a CAGR of 3.5% over the analysis...

  • Bladder Cancer
  • World
  • China
  • United States

Bladder Cancer - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer - Pipeline Review, H1 2020, provides an overview of the Bladder Cancer (Oncology) pipeline landscape. Bladder cancer occurs in tissues of the urinary bladder....

  • Bladder Cancer
  • World

Major players in the bladder cancer drugs market are Pfizer, Celgene Corporation, Eli Lilly, AstraZeneca, and Bristol-Myers Squibb. The global bladder cancer drugs market is expected to grow from $0.98 billion in 2020 to $1.14 billion in 2021 at a compound annual growth rate (CAGR) of 16.3%. The growth is mainly due to the companies...

  • Bladder Cancer
  • United States
  • Biologics Penetration Rate
  • Smoking Prevalence

“Non Muscle Invasive Bladder Cancer (NMIBC)– Pipeline Insight, 2020,” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Non-Muscle Invasive Bladder Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment...

  • Bladder Cancer
  • Taiwan
  • South Korea
  • Japan
  • World

Bladder Cancer Therapeutics and Diagnostics Market Report Overview Bladder Cancer Therapeutics and Diagnostics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Bladder Cancer Therapeutics and Diagnostics market types and applications....

  • Diagnostics
  • Bladder Cancer
  • World
  • Health Provider Density

‘Non-muscle Invasive Bladder Cancer (NMIBC)—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted NMIBC epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Non-muscle Invasive Bladder Cancer (NMIBC) Understanding Non-muscle...

  • Bladder Cancer
  • United States
  • Japan
  • Germany
  • United Kingdom
  • Spain
  • France
  • Italy

‘Non-muscle Invasive Bladder Cancer (NMIBC)—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted NMIBC epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Non-muscle Invasive Bladder Cancer (NMIBC) Understanding Non-muscle...

  • Bladder Cancer
  • United States
  • Japan
  • Germany
  • United Kingdom
  • Spain
  • France
  • Italy

Bladder Cancer - Pipeline Review, H2 2019 Summary The latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer - Pipeline Review, H2 2019, provides an overview of the Bladder Cancer (Oncology) pipeline landscape. Bladder cancer occurs in tissues of the urinary bladder....

  • Bladder Cancer
  • World

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) (Oncology) - Drugs in Development, 2021 Summary Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) (Oncology) - Drugs in Development, 2021 provides an overview of the Non Muscle Invasive Bladder Cancer (NMIBC)...

  • Bladder Cancer
  • World

Muscle Invasive Bladder Cancer (MIBC) (Oncology) - Drugs in Development, 2021 Summary Muscle Invasive Bladder Cancer (MIBC) (Oncology) - Drugs in Development, 2021 provides an overview of the Muscle Invasive Bladder Cancer (MIBC) pipeline landscape. The report provides comprehensive information...

  • Bladder Cancer
  • World

‘Non-muscle Invasive Bladder Cancer (NMIBC)—Market Insights, Epidemiology and Market Forecast–2030’ report delivers an in-depth understanding of the NMIBC, historical and forecasted epidemiology as well as the NMIBC market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The NMIBC market report...

  • Therapy
  • Bladder Cancer
  • United States
  • Japan
  • Germany
  • United Kingdom
  • Spain
  • France
  • Italy
  • Drug Approval
  • Health Expenditure

‘Non-muscle Invasive Bladder Cancer (NMIBC)—Market Insights, Epidemiology and Market Forecast–2030’ report delivers an in-depth understanding of the NMIBC, historical and forecasted epidemiology as well as the NMIBC market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The NMIBC market report...

  • Therapy
  • Bladder Cancer
  • United States
  • Japan
  • Germany
  • United Kingdom
  • Spain
  • France
  • Italy
  • Drug Approval
  • Health Expenditure

The ongoing clinical trial research report- “2019 Bladder Cancer Ongoing Clinical Trials Study” analyzes the current scenario of all active Bladder Cancer trials across the world. The report presents top level analysis of global Bladder Cancer clinical trials across countries, companies and universities. It is designed to provide clear understanding...

  • Bladder Cancer
  • Clinical Trial
  • World
  • APAC

The ongoing clinical trial research report- “2019 Muscle Invasive Bladder Cancer (MIBC) Ongoing Clinical Trials Study” analyzes the current scenario of all active Muscle Invasive Bladder Cancer (MIBC) trials across the world. The report presents top level analysis of global Muscle Invasive Bladder Cancer (MIBC) clinical trials across countries,...

  • Bladder Cancer
  • Clinical Trial
  • World
  • APAC

Bladder Cancer Overview

  • Bladder Cancer
  • China
  • Industrial Production
  • Hospital Beds Number

NON-MUSCLE INVASIVE BLADDER CANCER

  • Genitourinary System Disease
  • Bladder Cancer
  • Rare Earth
  • Surgical Laser
  • World
  • Europe
  • South America
  • APAC
  • Middle East
  • Africa
  • Health Expenditure
  • Cause-Specific Mortality Rate

Institut Curie is investigating small molecule for the treatment of bladder cancer.

  • Bladder Cancer
  • World
  • Industrial Production

Antisense RNAi Oligonucleotide to Inhibit Survivin and Bcl-## for Bladder Cancer – Drug Profile

  • Cancer
  • Therapy
  • Vaccine
  • Oncology
  • Oncology
  • Bladder Cancer
  • World
  • United Kingdom
  • Prescription Drug Sales

Abstract: Global Stoma/Ostomy Care Products Market to Reach $4.1 Billion by 2026 - Ostomy care products are used for managing faecas and urine from people with stoma, following a colostomy, ileostomy or urostomy procedure. Growth in the global market is set to be fueled by proliferation of bladder-related...

  • Autoimmune Disease
  • Bladder Cancer
  • World
  • Europe
  • Life Expectancy

Institut Curie is investigating small molecule for the treatment of bladder cancer.

  • Bladder Cancer
  • World
  • Industrial Production

Antisense RNAi Oligonucleotide to Inhibit Survivin and Bcl-## for Bladder Cancer – Drug Profile

  • Cancer
  • Therapy
  • Oncology
  • Bladder Cancer
  • Oncology
  • World
  • United Kingdom
  • Prescription Drug Sales

Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studies Muscle Invasive Bladder Cancer Drug Development Pipeline Study is the latest publication from VPA Research with comprehensive information of Muscle Invasive Bladder Cancer pipeline products. The Muscle Invasive Bladder Cancer pipeline guide presents complete...

  • Bladder Cancer
  • World

Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studies Non Muscle Invasive Bladder Cancer Drug Development Pipeline Study is the latest publication from VPA Research with comprehensive information of Non Muscle Invasive Bladder Cancer pipeline products. The Non Muscle Invasive Bladder Cancer pipeline guide...

  • Bladder Cancer
  • World

Gene Therapy to Target CD## Ligand for Malignant Melanoma and Bladder Cancer – Drug Profile

  • Gene Therapy
  • Pharmaceutical
  • Vaccine
  • Breast Cancer
  • Bladder Cancer
  • World
  • Stem Cell Transplantation

The global clinical trial report- “2019 Muscle Invasive Bladder Cancer Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Muscle Invasive Bladder Cancer. It presents in-depth analysis of Muscle Invasive Bladder Cancer clinical trials across markets and companies. The research work is for providing complete...

  • Bladder Cancer
  • Clinical Trial
  • World

“Non Muscle Invasive Bladder Cancer – Pipeline Insight, 2019” report outlays comprehensive insights of present scenario and growth prospects across Non Muscle Invasive Bladder Cancer. A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development stage, mechanism...

  • Bladder Cancer
  • World

Bladder Cancer Overview

  • Bladder Cancer
  • China
  • Industrial Production
  • Labour Force

Chart ##: Bladder Cancer Treatment Drugs Sales Volume (Billion

  • Bladder Cancer
  • China
  • Employment Costs
  • Business Birth